NTES
NetEase, Inc.
NTES's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over NTES overall, supported by stronger valuation and stronger modeled upside.
NTES Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Strong |
NTES's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
NTES PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $116 | -5.6% |
| Current | 16x | $123 | — |
| Fair | 19x | $140 | +14% |
| Expensive | 29x | $220 | +79% |
Historical ranges are pointers, not guarantees.
NTES's PE is 16x, but its earnings don't support one, so it isn't a reliable read right now.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over NTES in the historical PE scenario, which offers more potential upside but is not a forecast.
NTES Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
NTES has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
NTES Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $7.53 | -5.6% |
| Q1 2026 | $7.92 | +5% |
| Q4 2025 | $7.84 | +14% |
| Q3 2025 | $8.46 | +33% |
| Q2 2025 | $7.98 | +20% |
| Q1 2025 | $7.54 | +7.9% |
| Q4 2024 | $6.90 | +1.8% |
| Q3 2024 | $6.36 | +2.9% |
NTES earned $7.53 per share over the past year, down 5.6% from the year before.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over NTES on earnings, with more consistent year-over-year improvement.
NTES Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.5B | +7.6% |
| Q1 2026 | $4.6B | +6.1% |
| Q4 2025 | $4.1B | +3% |
| Q3 2025 | $4.3B | +8.2% |
| Q2 2025 | $4.2B | +9.4% |
| Q1 2025 | $4.3B | +7.4% |
| Q4 2024 | $4B | -1.4% |
| Q3 2024 | $3.9B | -3.9% |
NTES's revenue has grown year over year for six quarters in a row: $4.5B last quarter, up 7.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 40% | +7.7 points |
| Q1 2026 | 41% | +5.1 points |
| Q4 2025 | 30% | +1 points |
| Q3 2025 | 28% | +1 points |
| Q2 2025 | 32% | +5.1 points |
| Q1 2025 | 36% | +7.8 points |
| Q4 2024 | 29% | +3.9 points |
| Q3 2024 | 27% | -0.4 points |
NTES's operating margin was 40% last quarter, up 7.7 points from the same quarter a year ago, near the top of its range since 2019.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over NTES on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over NTES on profitability, with a higher operating margin.
NTES Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $1.5B | -3.7% |
| Q1 2026 | $2B | +16% |
| Q4 2025 | $2.2B | +14% |
| Q3 2025 | $1.9B | +25% |
| Q2 2025 | $1.6B | +74% |
| Q1 2025 | $1.7B | +27% |
| Q4 2024 | $1.9B | +12% |
| Q3 2024 | $1.5B | +18% |
NTES's free cash flow has been positive every quarter for seven years: $7.5B over the past year, up 13% from the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over NTES on cash flow, with stronger typical year-over-year growth.
NTES Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -1.1M shares |
| 1 year | +0.2% | +1.4M shares |
| 3 years | -0.8% | -5.5M shares |
| 5 years | -4.9% | -32.9M shares |
| Available history | -1.4% | -9M shares |
NTES has 644M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $268.4M |
| Q1 2026 | $197.2M |
| Q4 2025 | $2.4M |
| Q3 2025 | $5.3M |
| Q2 2025 | $53.4M |
| Q1 2025 | $45.6M |
| Q4 2024 | $239.4M |
| Q3 2024 | $599.4M |
NTES spent $473M buying back its own shares over the past year, down 50% from the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over NTES on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
NTES Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -0.5x | Net Cash |
| Q2 2025 | -1.0x | Net Cash |
| Q1 2025 | -0.8x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
| Q3 2024 | -0.3x | Net Cash |
NTES has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
NTES Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.3 | Neutral |
| Stochastic | 49.8 | Neutral |
NTES's weekly RSI is 50 (neutral) and its Stochastic is 50 (neutral).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
NTES PE vs Technology Sector
| Metric | NTES | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 28x | 42% below |
| PE % | 26 | 35 | 9 pts below |
NTES has the edge over NVDA on valuation relative to its sector.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
NTES Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $120.9 | 1.4% above |
| 20 week MA | $123.3 | 0.5% below |
| 50 week MA | $123.5 | 0.7% below |
| 100 week MA | $122.1 | 0.5% above |
| 200 week MA | $108.4 | 13% above |
NTES has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
NTES Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $61.2 | $92.7 | +51% |
| 2021 | $92.7 | $97.8 | +5.6% |
| 2022 | $97.8 | $71.1 | -27% |
| 2023 | $71.1 | $93.2 | +31% |
| 2024 | $93.2 | $91.5 | -1.8% |
| 2025 | $91.5 | $138.1 | +51% |
| 2026 YTD | $138.1 | $122.6 | -11% |
NTES has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.